Permanent I-125 seed implant brachytherapy for prostate carcinoma

Atsunori Yorozu, K. Toya, T. Ohashi, M. Okada, T. Kasamatsu, R. Ito, T. Monma, S. Saito

研究成果: Article査読

抄録

Permanent prostate brachytherapy has been increasingly used as a highly curative treatment for clinically localized prostate cancer. Many brachytherapy studies have reported favorable long-term biochemical outcomes. with a minimal morbidity that compares with surgery or external beam radiotherapy. So I-125 seed implant must be a best treatment option for a low risk group. There are some contraindications or limitation for brachytherapy. There is a learning curve as well. Combined treatment with external beam or hormone treatment may be necessary for intermediate or high risk groups. It is possible that high-quality brachytherapy may have more favorable results.

本文言語English
ページ(範囲)619-624
ページ数6
ジャーナルJapanese Journal of Clinical Radiology
50
5
出版ステータスPublished - 2005 6 13
外部発表はい

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

フィンガープリント 「Permanent I-125 seed implant brachytherapy for prostate carcinoma」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル